Alectinib, an anaplastic lymphoma kinase (ALK) inhibitor, as a bridge to allogeneic stem cell transplantation in a patient with ALK-positive anaplastic large-cell lymphoma refractory to chemotherapy and brentuximab vedotin
| Image |  |
|---|---|
| Description | scientific article published on 15 November 2019 |
| Author/s |
author: Tomotaka Suzuki Shunsuke Hatta Wataru Munakata Sayako Yuda Suguru Fukuhara Koji Izutsu Dai Maruyama Akiko Miyagi-Maeshima Shinichi Makita |
| Publication date | November 15, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |